Sequence 34 from Patent US 20060122119

General Information


DRACP ID  DRACP01267

Peptide Name   Sequence 34 from Patent US 20060122119

Sequence  ILDTAGQEEY

Sequence Length  10

UniProt ID  Q54BW4  Q75J93  P01120  P01119  P01114  P22126  P22279  P51539  P34726  P01111  Q5RD87  Q91806  Q95ME4  B4LY29  P23175  P01112  P01113  B4NJ72  P12825  Q04970  P08556  P34729  P15064  B4JFU8  B3M185   

PubChem CID  Not available

Origin  Homo sapiens

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01267

Helicity  Not available

Linear/Cyclic  Not available

Disulfide/Other Bond  Not available

N-terminal Modification  Not available

C-terminal Modification  Not available

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C49H75N11O20

Absent amino acids  CFHKMNPRSVW

Common amino acids  E

Mass  129892

Pl  3.42

Basic residues  0

Acidic residues  3

Hydrophobic residues  3

Net charge  -3

Boman Index  -1800

Hydrophobicity  -63

Aliphatic Index  88

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  1490

Absorbance 280nm  165.56

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US 2006/0122119 A1

Patent Title  Peptides for use in antitumor immunotherapy.

Other Iinformation  Granted Patent Family: 10s / 10ex; Family Jurisdictions: CA, AU, FR, WO, US, EP, JP; Legal Status: Discontinued; Application No: 50633405; Filed:May 25, 2005; Published: Jun 8, 2006; Earliest Priority: Mar 4, 2002

Other Published ID  CA2477762A1  EP1481009A2  WO2003074565A2  WO2003074565A3 




DRACP is developed by Dr.Zheng's team.